Loring Wolcott & Coolidge Fiduciary Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221M | Buy |
|
|||||
|
2025
Q1 | $226M | Buy |
|
|||||
|
2024
Q4 | $305M | Sell |
|
|||||
|
2024
Q3 | $293M | Sell |
|
|||||
|
2024
Q2 | $293M | Buy |
|
|||||
|
2024
Q1 | $289M | Sell |
|
|||||
|
2023
Q4 | $288M | Sell |
|
|||||
|
2023
Q3 | $240M | Buy |
|
|||||
|
2023
Q2 | $276M | Buy |
|
|||||
|
2023
Q1 | $300M | Buy |
|
|||||
|
2022
Q4 | $286M | Buy |
|
|||||
|
2022
Q3 | $261M | Buy |
|
|||||
|
2022
Q2 | $276M | Buy |
|
|||||
|
2022
Q1 | $296M | Buy |
|
|||||
|
2021
Q4 | $331M | Buy |
|
|||||
|
2021
Q3 | $274M | Buy |
|
|||||
|
2021
Q2 | $212M | Buy |
|
|||||
|
2021
Q1 | $157M | Buy |
|
|||||
|
2020
Q4 | $114M | Buy |
|
|||||
|
2020
Q3 | $98M | Buy |
|
|||||
|
2020
Q2 | $79.9M | Sell |
|
|||||
|
2020
Q1 | $62.9M | Sell |
|
|||||
|
2019
Q4 | $72.1M | Sell |
|
|||||
|
2019
Q3 | $64.6M | Buy |
|
|||||
|
2019
Q2 | $64.5M | Buy |
|
|||||
|
2019
Q1 | $59.9M | Sell |
|
|||||
|
2018
Q4 | $49.1M | Buy |
|
|||||
|
2018
Q3 | $51.4M | Buy |
|
|||||
|
2018
Q2 | $41.6M | Buy |
|
|||||
|
2018
Q1 | $40.4M | Buy |
|
|||||
|
2017
Q4 | $36.5M | Buy |
|
|||||
|
2017
Q3 | $35.9M | Buy |
|
|||||
|
2017
Q2 | $32.8M | Buy |
|
|||||
|
2017
Q1 | $27M | Buy |
|
|||||
|
2016
Q4 | $24.7M | Buy |
|
|||||
|
2016
Q3 | $21.1M | Buy |
|
|||||
|
2016
Q2 | $19M | Buy |
|
|||||
|
2016
Q1 | $17.3M | Buy |
|
|||||
|
2015
Q4 | $11.4M | Buy |
|
|||||
|
2015
Q3 | $3.84M | Hold |
|
|||||
|
2015
Q2 | $3.84M | Buy |
|
|||||
|
2015
Q1 | $1.7M | Buy |
|
|||||
|
2014
Q4 | $167K | Buy |
|
|||||
|
2014
Q3 | $113K | Sell |
|
|||||
|
2014
Q2 | $127K | Hold |
|
|||||
|
2014
Q1 | $129K | Hold |
|
|||||
|
2013
Q4 | $120K | Hold |
|
|||||
|
2013
Q3 | $99K | Sell |
|
|||||
|
2013
Q2 | $125K | Buy |
|